Dr Jun Liu
MBBS, MSc, PhD
Jun Liu studied clinical medicine at Shanghai Jiao Tong University, graduating in 2013. She did one-year research training at the Department of Endocrine and Metabolic Diseases, Rui-Jin Hospital, Shanghai. In 2016, she obtained her MSc at Erasmus Medical Center, Rotterdam. She was then employed as a scientific researcher there.
In 2019, she finished her PhD thesis titled “Integration of Multi-Omics in Type 2 Diabetes and Related Disorders Research”. She was the convener of the Biobanking and BioMolecular resources Research Infrastructure of the Netherlands (BBMRI-NL) medication working group. From early 2019 she has been the convener in the Cohorts of Heart and Ageing Research in Genomic Epidemiology (CHARGE) metabolomics working group.
Jun joined NDPH in 2019. She mainly works on integration of multi-omics in cardiometabolic diseases and related neurological disorders. Her current research portfolio includes implementing novel analytic approaches to high dimensional analyses involving (epi)genetic, transcriptomic, proteomic, metabolomic and microbiome data of epidemiological cohorts.
The trans-ancestral genomic architecture of glycemic traits.
Chen J. et al, (2021), Nat Genet
Identification of Biomarkers for the Prevention of Chronic Disease
Boccia S. et al, (2021), SpringerBriefs in Public Health, 9 - 32
A cross-omics integrative study of metabolic signatures of chronic obstructive pulmonary disease.
Prokić I. et al, (2020), BMC Pulm Med, 20
Integration of epidemiologic, pharmacologic, genetic and gut microbiome data in a drug-metabolite atlas.
Liu J. et al, (2020), Nat Med, 26, 110 - 117
Lipidomic profiling identifies signatures of metabolic risk.
Yin X. et al, (2020), EBioMedicine, 51